Document is current
Any future updates will be listed below
-
Authors
Blom, Dirk J.
Marais, A. David
Raal, Frederick J.
-
Funding
Funding for this research was provided by:
University of Cape Town
- License Information
-
More Information
Article History
Accepted: 19 December 2024
First Online: 3 January 2025
Declarations
:
: DJ Blom DB reports personal fees from Amgen, Amryt, MSD, Novartis, Sanofi and Servier and outside the submitted work.A David Marais ADM reports no personal fees from the companies producing the agents discussed but had support for the performance of the study of atorvastatin and lomitapide by Warner Lambert Parke Davis and Aegerion, respectively.FJ Raal FJR reports personal fees from LIB Therapeutics, Amgen, Sanofi, Regeneron Pharmaceuticals, Inc., and Novartis outside the submitted work.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
